As we celebrate the 50^th anniversary of AdvaMed, the Medtech Association, we recognize the critical role the medtech industry has played – and always will play – in transforming people’s lives. As the current Administration launches it’s “Make America Healthy Again” initiative, it’s important that we remember that the medtech industry has been making America healthy again since its inception. The story of medtech is the most powerful story in health care and it really is a story as old as toolmaking itself. It is the story of getting people back to good health. Back to “normal.” Back to playing with their grandchildren. Back to moving, walking, and even seeing again. Back to life. Continue reading→

PMC, the Personalized Medicine Coalition, announced that George Poste, DVM, PhD, Regents Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University, will receive the 2025 Award for Leadership in Personalized Medicine at this year’s Personalized Medicine Conference, to be held November 13–14 at the Ritz Carlton, Laguna Niguel, in Dana Point, California. This award recognizes Dr. Poste’s substantial multi-decade contributions to the advancement of personalized medicine and his enduring impact on science, technology, and policy.Continue reading→

Marvin J. Slepian, MD, JD, a Regents Professor of medicine, radiology and imaging sciences and surgery at the University of Arizona College of Medicine – Tucson and of biomedical engineering at the U of A College of Engineering, received this year’s University Distinguished Innovation and Entrepreneurship Award. Continue reading→

Researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) agent powered by a large language model (LLM) that creates more accurate and informative descriptions of biological processes and their functions in gene set analysis than current systems.Continue reading→

Findings suggest that the patients themselves produce molecules that could reawaken their immune system to battle lung cancerContinue reading→

Every Stage, Every Step: Transforming Lives Through Optimized Drug DevelopmentContinue reading→

Suzanne Pfister, an extraordinary leader and public servant whose tenure as Vitalyst Health Foundation’s President and CEO transformed the organization and  inspired paradigm-shifting change across Arizona’s health landscape.
Continue reading→

TUCSON, Ariz., July 16, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings extensive experience in biopharmaceutical leadership, clinical development, and regulatory strategy to C-Path’s growing efforts to advance global drug development and data-driven science.Continue reading→

University Hospitals Cleveland Medical Center physician awarded funding to advance novel therapy for IBD.Continue reading→